| | Business Summary | | Immunex
Corporation
is
a
biopharmaceutical
company
dedicated
to
developing
immune
system
science
to
protect
human
health.
Applying
its
scientific
expertise
in
the
fields
of
immunology,
cytokine
biology,
vascular
biology,
antibody-based
therapeutics
and
small
molecule
research,
the
Company
works
to
discover
new
targets
and
new
therapeutics
for
treating
rheumatoid
arthritis,
asthma
and
other
inflammatory
diseases,
as
well
as
cancer
and
cardiovascular
diseases.
The
Company's
products
are
marketed
in
the
United
States
and
are
available
by
prescription
only.
Immunex's
product
revenues
come
from
products
in
two
major
therapeutic
classes,
anti-inflammatory
and
specialty
therapeutics,
principally
oncology
and
multiple
sclerosis. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Immunex
is
a
biopharmaceutical
firm
that
develops,
markets,
and
manufactures
innovative
therapeutic
products
for
the
treatment
of
cancer,
infectious
diseases,
and
immunological
disorders.
For
the
six
months
ended
6/30/01,
revenues
increased
16%
to
$456.1
million.
Net
income
increased
20%
to
$88.7
million.
Revenues
reflect
strong
demand
for
ENBREL.
Earnings
reflect
increased
interest
income
due
to
investment
funds
from
the
issuance
of
convertible
debt. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Edward Fritzky, 50
Chairman,
Pres, CEO | $2.2M | $13.0M | David Mann, 41
CFO,
Exec. VP, Treasurer | 539K | 7.6M | Peggy Phillips, 47
Exec.
VP, COO, Director | 852K | 1.5M | Douglas Williams, 42
Exec.
VP, CTO, Director | 640K | 2.6M | Barry Pea, 43
Sr.
VP, Gen. Counsel, Sec. | 511K | 3.9M | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/i/imnx.gif)